This article examines viral and non-viral vectors in gene therapy, highlighting their mechanisms, advantages, and limitations ...

BioViva’s journey in gene therapy began with its use of an adeno-associated virus (AAV) vector. The company’s lead gene therapy, BV-702, is AAV-based and is in preclinical development for ...

Adenoviral vectors will transduce a wide range of target cells resulting in high-level gene expression ... can be excised with two restriction enzymes with almost unique cleavage sequences absent in ...

But the opportunity to leverage microgravity conditions can unlock a lot of untouched potential by pushing the boundaries of science in a unique ... vector would be able to deliver gene therapy to ...